CTP extends duration of action of FSH in Phase III trial

Schering-Plough has successfully completed a Phase III trial of its long-acting fertility hormone corifollitropin alfa (FSH-CTP). The duration of action is expanded by the addition of CTP from Modigene.

Irribow (ramosetron) approved in Japan for diarrhea predominant IBS

Astellas have announced the Japanese  approval of 5-HT3 antagonist Irribow for the treatment of diarrhea predominant Irritable Bowel Syndrome in Men

Anesiva insitate Phase II trual of Adlea in Arthroscopic Shoulder Surgery

Anesiva have begun a Phase II clinical trial of Adlea, the company’s long-acting capsaicin product in for the management of acute pain in patients undergoing arthroscopic shoulder surgery involving rotator cuff repair.